Last updated: August 17, 2026

幹細胞療法被認為是治療退行性骨關節疾病(OA)的潛在方法。然而,幹細胞的最佳劑量尚不清楚,這限制了其臨床應用。本文探討了不同劑量幹細胞療法對OA的劑量效應關係,為確定最佳劑量策略提供了見解。

幹細胞劑量對軟骨再生和疼痛緩解的影響

幹細胞劑量對軟骨再生和疼痛緩解有顯著影響。低劑量幹細胞可能有助於軟骨基質的合成,而高劑量幹細胞則促進軟骨細胞的增殖和分化。此外,高劑量幹細胞已被證明能更有效地減輕疼痛,這可能是由於其對炎症和神經病變的抑制作用。

劑量依賴性與治療反應的相關性

幹細胞劑量和治療反應之間存在劑量依賴性關係。低劑量幹細胞可能產生亞閾值效應,而高劑量幹細胞則導致過度生長或異位形成。因此,確定一個最佳劑量至關重要,既能提供治療益處,又能最小化不良事件的風險。

Scientific case review

Scientific Case Review

Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?

Share your question with our scientific research team and receive information focused on the areas of current research that may be relevant to your case.

  • Review of the information you provide
  • Relevant research and clinical program information
  • A clear response focused on your situation
What happens next? Send your question, receive a focused scientific review, and get a clear response about research and clinical programs relevant to your situation.
Your scientific review will be prepared by Dr. Helen Melnik, PhD , who has more than 25 years of experience in stem cell research and international clinical programs.

No obligation. Your question will be reviewed confidentially.

Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.

WhatsApp